PSTV icon

Plus Therapeutics
PSTV

Overview Fund Activity

18 hedge funds and large institutions have $4.51M invested in Plus Therapeutics in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
1
Closed
3
Calls
$28K
Puts
–
Net Calls
+$28K
Net Calls Change
+$38K

Top Buyers

1
PCM
1
Perkins Capital Management
Minnesota
$962K
2
SM
2
Sabby Management
Florida
$1.79M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$674K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$165K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$188K

Top Sellers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$0
2
VKH
2
Virtu KCG Holdings
New York
$0
3
Citadel Advisors
3
Citadel Advisors
Florida
$0
4
Simplex Trading
4
Simplex Trading
Illinois
$9K
5
UBS Group
5
UBS Group
Switzerland
$1K
Name Holding Trade Value Shares
Change 		Shares
Change %
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$146 -$213 – –
VKH
27
Virtu KCG Holdings
New York
– -$73K -6 Closed
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
– -$74K -6 Closed
Citadel Advisors
29
Citadel Advisors
Florida
– -$25K -2 Closed
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K – –
1
2